Multisystemic Diseases

Imagen equipo

Group leader

Luis Manzano Espinosa

luis.manzano(ELIMINAR)@salud.madrid.org

91 336 92 04

Principal Investigator

  • Vicente Gómez del Olmo

Collaborating Staff

  • Olivia Sánchez Sánchez
  • Mónica Angélica López Rodríguez
  • Ángel Manuel Ruedas López
  • Ignacio Barbolla Díaz
  • Nuria Bara Ledesma
  • Martín Fabregate Fuente
  • Andrés González García
  • María Belén Pumares Álvarez
  • Rosa María Fabregate Fuente
  • Raúl Antonio Ruiz Ortega
  • Pau Llacer Iborra
  • Luis Adrián Viteri Noël
  • Susana Tello Blasco
  • Jose Luis Calleja Lopez
  • Fernando Daniel Hidalgo Salinas
  • Sergio José Diz Fariña
  • Genoveva Teresa López Castellanos
  • Cecilia Suárez Carantoña
  • Judith Jiménez Esteban
  • Cristina Fernández Soler
  • Javier Soto Pérez-Olivares
  • Almudena Vázquez Santos
  • Cristina Bianca Pomana
  • Berta Rojo Hurtado
Imagen equipo

Group leader

Luis Manzano Espinosa

luis.manzano(ELIMINAR)@salud.madrid.org

91 336 92 04

Principal Investigator

  • Vicente Gómez del Olmo

Collaborating Staff

  • Olivia Sánchez Sánchez
  • Mónica Angélica López Rodríguez
  • Ángel Manuel Ruedas López
  • Ignacio Barbolla Díaz
  • Nuria Bara Ledesma
  • Martín Fabregate Fuente
  • Andrés González García
  • María Belén Pumares Álvarez
  • Rosa María Fabregate Fuente
  • Raúl Antonio Ruiz Ortega
  • Pau Llacer Iborra
  • Luis Adrián Viteri Noël
  • Susana Tello Blasco
  • Jose Luis Calleja Lopez
  • Fernando Daniel Hidalgo Salinas
  • Sergio José Diz Fariña
  • Genoveva Teresa López Castellanos
  • Cecilia Suárez Carantoña
  • Judith Jiménez Esteban
  • Cristina Fernández Soler
  • Javier Soto Pérez-Olivares
  • Almudena Vázquez Santos
  • Cristina Bianca Pomana
  • Berta Rojo Hurtado

STRATEGIC OBJECTIVES

  • To advance our understanding of the pathophysiological mechanisms involved in various multisystem diseases.
  • To identify biomarkers and potential therapeutic targets, as well as to develop clinically useful prognostic models for complex acute and chronic conditions.
  • To develop, apply, and evaluate new diagnostic and therapeutic technologies and tools, as well as new prevention and treatment strategies, in patients with complex conditions.
  • To enhance synergies between research lines and collaboration with other IRYCIS groups, researchers, and structures.
  • To integrate and actively participate in cooperative networks, working groups, and multicenter, national and international registries.
  • To strengthen and expand alliances and collaborations with the business sector in clinical research.
  • To generate new lines of research that are complementary to current ones and aligned with the strategic objectives of IRYCIS and national and European plans.

RESEARCH LINES

  • Heart failure in complex chronic patients.
  • Pathophysiological and therapeutic bases of cardiovascular prevention.
  • Prophylaxis of venous thromboembolism.
  • Hereditary haemorrhagic telangiectasia.
  • Congenital metabolic diseases in adults.
  • Systemic autoimmune diseases.

Location

Internal Medicine Department

4th floor right side. Control B

Ramón y Cajal University Hospital 

Keywords

multisystem diseases, heart failure, complex chronic patient, cardiovascular prevention, venous thromboembolism, systemic autoimmune diseases, rare diseases, hereditary hemorrhagic telangiectasia, congenital metabolic diseases in adults, elderly patient, multipathological patient